ShockWave Medical, Inc. (SWAV)
NASDAQ: SWAV · IEX Real-Time Price · USD
325.63
+3.02 (0.94%)
At close: Mar 28, 2024, 4:00 PM
330.00
+4.37 (1.34%)
After-hours: Mar 28, 2024, 7:56 PM EDT

ShockWave Medical Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for ShockWave Medical stock have an average target of 260.08, with a low estimate of 165 and a high estimate of 310. The average target predicts a decrease of -20.13% from the current stock price of 325.63.

Analyst Consensus: Buy
Target Low Average Median High
Price $165 $260.08 $283 $310
Change -49.33% -20.13% -13.09% -4.80%
* Price targets were last updated on Feb 16, 2024.

Analyst Ratings

The average analyst rating for SWAV stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 555555
Buy 443333
Hold 333333
Sell 111111
Strong Sell 000000
Total 131312121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Maintains
$200$210
Hold Maintains $200$210 -35.51% Feb 16, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$275$290
Buy Maintains $275$290 -10.94% Feb 16, 2024
Needham
Needham
Strong Buy
Maintains
$260$286
Strong Buy Maintains $260$286 -12.17% Feb 16, 2024
Morgan Stanley
Morgan Stanley
Buy
Maintains
$284$223
Buy Maintains $284$223 -31.52% Dec 4, 2023
Morgan Stanley
Morgan Stanley
Buy
Maintains
$313$284
Buy Maintains $313$284 -12.78% Nov 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
939.11M
from 730.23M
Increased by 28.60%
Revenue Next Year
1.15B
from 939.11M
Increased by 22.78%
EPS This Year
4.94
from 3.85
Increased by 28.31%
EPS Next Year
6.24
from 4.94
Increased by 26.36%
Year 2019202020212022202320242025202620272028
Revenue
42.93M67.79M237.15M489.73M730.23M939.11M1.15B1.38B1.59B1.87B
Revenue Growth
250.05%57.92%249.83%106.51%49.11%28.60%22.78%19.86%14.91%17.51%
EPS
-2.14-1.99-0.265.703.854.946.247.578.54-
EPS Growth
-----32.46%28.31%26.36%21.35%12.72%-
No. Analysts -----13131053
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 971.3M 1.2B 1.5B 1.8B 1.9B
Avg 939.1M 1.2B 1.4B 1.6B 1.9B
Low 899.1M 1.1B 1.2B 1.4B 1.8B

Revenue Growth

Revenue Growth 20242025202620272028
High
33.0%
31.3%
31.0%
32.6%
21.0%
Avg
28.6%
22.8%
19.9%
14.9%
17.5%
Low
23.1%
12.9%
4.9%
-0.7%
12.9%

EPS Forecast

EPS 2024202520262027
High 6.55 7.62 8.88 9.90
Avg 4.94 6.24 7.57 8.54
Low 3.91 5.05 6.23 6.83

EPS Growth

EPS Growth 2024202520262027
High
70.2%
54.3%
42.3%
30.7%
Avg
28.3%
26.4%
21.3%
12.7%
Low
1.6%
2.2%
-0.1%
-9.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.